Richard Pzena's position in Bristol-Myers Squibb is currently worth $968M. That's 2.84% of their equity portfolio (12th largest holding). The first Bristol-Myers Squibb trade was made in Q3 2019. Since then Richard Pzena bought shares fourteen more times and sold shares on twelve occasions. The stake costed the investor $905M, netting the investor a gain of 6.9% so far.